abstract |
The invention relates to novel compounds of formula (I), in which R, R1, R2, R3 and R4 are defined as cited in claim 1. Said compounds are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or treatment of thromboembolic diseases and for the treatment of tumours. |